Geoff Race - 16 Feb 2022 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
President
Signature
/s/ Ryan Sansom, Attorney-in-Fact
Issuer symbol
NERV
Transactions as of
16 Feb 2022
Transactions value $
$0
Form type
4
Filing time
18 Feb 2022, 15:34:42 UTC
Next filing
14 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Employee Stock Option (right to buy) Award $0 +200K $0.00 200K 16 Feb 2022 Common Stock 200K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter.